LifestyleBreaking
Archived — This article has been archived. The information may be outdated.
Centre bans 16 fixed-dose drug combinations citing lack of therapeutic justification
The Hindu··20 Jun
The Hindu reported that the Union Health Ministry prohibited manufacture, sale and distribution of 16 FDC drugs on June 20, saying they lack therapeutic justification and pose risks outweighing benefits after DTAB expert review.
Prism
What It Means For You
- Some common antibiotic and painkiller combinations are now prohibited.
- Patients should check prescriptions for banned FDC medicines.
- The ban aims to promote rational drug use and patient safety.
What's Happening
- 16 FDC drugs were banned with immediate effect on June 20.
- DTAB found the combinations therapeutically unjustified.
- State regulators must enforce the prohibition nationwide.
Regulatory Context
- FDCs combine two or more drugs in fixed ratios.
- India has banned irrational FDCs in previous years too.
- The review followed Supreme Court-mandated scrutiny.
all-newstop-storiesdaily-roundup
